Study guide
7.3 Automated Medication Systems, Remote Dispensing & Telepharmacy
Mississippi MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Mississippi MPJE Overview
1.1 Mississippi MPJE Format, Logistics & Official Blueprint 1.2 Study Strategy & Federal vs. Mississippi Legal Hierarchy 1.3 Federal & State Regulatory Authorities & Oversight
2 Chapter 2: Mississippi Pharmacy Governance, Board Structure & Licensure
2.1 Mississippi Board of Pharmacy: Structure, Authority & Operations 2.2 Pharmacist Licensure, Examination, Reciprocity & Continuing Education 2.3 Pharmacy Interns, Externs & Preceptor Requirements 2.4 Pharmacy Technicians: Registration, Scope & Supervision Ratios 2.5 Disciplinary Proceedings, Impairment & Current Monitoring
3 Chapter 3: Pharmacist Practice Standards & Prescribing Authority
3.1 Prescription Requirements, Formats & Electronic Prescribing (EPCS) 3.2 Prescriptive Authority in Mississippi: Physicians, Mid-Level Practitioners & Out-of-State 3.3 Collaborative Drug Therapy Management (CDTM) & Institutional Protocols 3.4 Patient Counseling, Prospective DUR & OBRA '90 Mandates 3.5 HIPAA, Patient Privacy & Confidentiality of Pharmacy Records
4 Chapter 4: Controlled Substances: Scheduling, Ordering & Security
4.1 Federal & Mississippi Controlled Substance Scheduling 4.2 DEA Registration, Mississippi Permitting & Physical Security 4.3 Schedule II Ordering: Single-Sheet DEA Form 222 & Electronic CSOS 4.4 Controlled Substance Inventories: Mississippi Annual Mandate 4.5 Controlled Substance Disposal (DEA Form 41) & Theft/Loss Reporting Protocols
5 Chapter 5: Dispensing Controlled Substances & Prescription Processing
5.1 Schedule II Prescriptions: Issuance, Emergency Oral Dispensing & Sequential Prescriptions 5.2 Partial Filling of Controlled Substances: CARA, Out-of-Stock & Long-Term Care 5.3 Schedule III–V Prescriptions: Refill Limitations, Authorizations & Expirations 5.4 Prescription Transfers: Federal & Mississippi Requirements 5.5 Corresponding Responsibility, Red Flags & Legitimate Medical Purpose
6 Chapter 6: Mississippi Prescription Monitoring Program & Public Health Mandates
6.1 Mississippi Prescription Monitoring Program (MS PMP Gateway): Mandates & 24-Hour Reporting 6.2 Opioid Prescribing Limits, MME Calculations & Acute Pain Restrictions 6.3 Naloxone Standing Order, Overdose Prevention & Harm Reduction Dispensing 6.4 Behind-the-Counter Sales: Pseudoephedrine & Ephedrine Regulations 6.5 Pharmacist Immunization Authority & Protocol Administration in Mississippi
7 Chapter 7: Pharmacy Operations, Permits & Facilities
7.1 Community Pharmacy Permits, Pharmacist-in-Charge (PIC) Duties & Staffing 7.2 Institutional & Hospital Pharmacy Practice Regulations 7.3 Automated Medication Systems, Remote Dispensing & Telepharmacy 7.4 Non-Resident (Mail-Order) Pharmacies, Licensure & Wholesale Distributors 7.5 Drug Supply Chain Security Act (DSCSA), Track-and-Trace & Product Quarantines
8 Chapter 8: Compounding Standards, Safety & Product Selection
8.1 Non-Sterile Compounding (USP <795>): Categories, Beyond-Use Dating & Quality Assurance 8.2 Sterile Compounding (USP <797>): Cleanrooms, ISO Classifications & Aseptic Protocols 8.3 Hazardous Drug Handling (USP <800>): Engineering Controls, PPE & Spill Protocols 8.4 Generic Drug Substitution, FDA Orange Book & Purple Book Biosimilars 8.5 Repackaging, Unit-Dose Beyond-Use Dating & FDA Drug Recall Classifications
9 Chapter 9: Review, Clinical Scenarios & High-Yield Calculations
9.1 High-Yield Scenario Review: Resolving Complex Federal vs. Mississippi Legal Conflicts 9.2 Pharmacy Law Calculations: DEA Verification, Days Supply, Limits & Ratios 9.3 Rapid-Fire Master Review: Key Timelines, Quantities, Retention Periods & Forms 9.4 Exam Day Strategy, Computer-Adaptive Pacing & Distractor Elimination 9.5 High-Frequency MPJE Pitfalls & Distractor Traps
7.3 Automated Medication Systems, Remote Dispensing & Telepharmacy
Key Takeaways Explain This Topic AI
Article XXXIX requires prior written Board notice before installation or removal of an automated pharmacy system; it does not state that routine installation awaits a separate approval order.
A pharmacist review should occur before medication is removed from an automated system, but a first dose or emergency dose may be released without prior review when the system and policy safeguards apply.
Centralized prescription processing may divide dispensing, DUR, claims, refill-authorization, therapeutic-intervention, product, and release functions among pharmacies, but each task retains its professional, permit, record, and accountability requirements.
Article XLVIII telepharmacy sites are restricted by the 15-mile rule, use one and only one certified technician with at least two years’ experience, and a supervising pharmacist may oversee no more than two sites.
The remote pharmacist approves every prescription and counsels on all new and refill prescriptions; if the audiovisual/system connection is interrupted, dispensing ceases until restored.
Last updated: August 2026
Automated Pharmacy Systems and Telepharmacy
Mississippi regulates automated systems in Article XXXIX and telepharmacy in Article XLVIII . Both rely on technology but are different models: an automated system stores or distributes medication under pharmacy control, while telepharmacy connects a remote pharmacist to a staffed remote site.
Automated pharmacy systems
Before installing or removing an automated pharmacy system, the pharmacy gives the Board prior written notice with the required location and system information. The current text should not be recast as a separate advance “approval” requirement unless the Board specifically conditions the installation.
The pharmacist-in-charge develops policies for security, authorized access, stocking, accuracy checks, overrides, discrepancies, recalls, downtime, quality assurance, and records. Qualified personnel may stock the system under pharmacist supervision. The loading process verifies identity, strength, dosage form, lot/expiration where required, pocket, and quantity; barcode or machine checks support but do not replace accountability.
A pharmacist should review the order before medication is removed. The rule recognizes that a first dose or emergency dose may be removed before prospective pharmacist review when institutional policy and system safeguards permit. The pharmacist then reviews as promptly as patient care requires. Do not invent a universal legal statement that every override must be reviewed within exactly 24 hours; a hospital may adopt that stricter policy, but it is not the current Article XXXIX number.
System records identify access, transaction, medication, patient or destination, date/time, quantity, and responsible personnel and are retained for two years . Investigate discrepancies, prevent shared credentials, remove access promptly, and preserve the audit trail.
Telepharmacy site eligibility
Article XLVIII establishes a remote site connected by real-time audiovisual technology to a supervising Mississippi pharmacy and pharmacist. The site may not be located within 15 miles of an existing permitted pharmacy under the rule’s location restriction. A supervising pharmacist may oversee no more than two telepharmacy sites .
Each site uses one and only one certified pharmacy technician who has at least two years of experience . No pharmacy intern is used at the remote site as a substitute, and the technician remains included in the supervising pharmacist’s technician ratio. The site cannot simply add a second technician for peak volume.
Prescription workflow
The technician performs authorized technical tasks while the remote pharmacist observes and communicates through the system. The pharmacist conducts DUR, verifies patient and prescription, checks the selected product and label, and approves every prescription before release . The pharmacist provides counseling for all new and refill prescriptions , not only when the patient asks a technician a clinical question.
If the required communication or verification system is interrupted, prescription processing and dispensing at the remote site cease until the connection is restored . A phone call without the required system is not an automatic substitute.
The supervising pharmacist inspects each site at intervals not exceeding 30 days and documents the inspection. Inspection and telepharmacy records are maintained for two years . Policies cover security, controlled substances if permitted, inventory, recalls, temperature, errors, patient privacy, emergencies, and closure.
Key distinction
An automated cabinet inside an institution can have a safeguarded emergency first-dose pathway; a telepharmacy technician cannot use “emergency” to bypass the remote pharmacist’s prescription approval. The telepharmacy site depends on an active remote pharmacist connection for each release.
Exam method
Automated system: prior written notice, qualified supervised stocking, review should precede removal with safeguarded first/emergency exception, two-year records, no universal 24-hour override rule . Telepharmacy: 15 miles, one certified technician with two years, two sites per supervisor, every prescription approved, every new/refill counseled, stop on system failure, inspect within 30 days, records two years .
Technology failure examples
An automated cabinet records an emergency first dose before pharmacist review. The audit trail should identify patient, order, drug, user, time, and reason; the pharmacist reviews promptly and the pharmacy evaluates patterns. The absence of a 24-hour statutory number does not permit indefinite review.
At a telepharmacy site, loss of video or product-verification connection is different. The certified technician cannot release a waiting refill based on last month’s pharmacist approval; processing stops until the system returns and the pharmacist approves the actual prescription. Likewise, a second technician cannot work temporarily merely because the first takes lunch—the “one and only one” staffing design must remain satisfied.
The supervising pharmacist’s maximum of two telepharmacy sites is separate from ordinary employment at the supervising pharmacy. Policies should prevent simultaneous workload from undermining real-time observation, counseling, and final approval at either site.
Centralized prescription processing
Mississippi's definitions treat centralized prescription processing as one pharmacy processing another pharmacy's request to fill or refill an order or performing functions such as dispensing, DUR, claims adjudication, refill authorization, and therapeutic intervention. The term is broader than a warehouse that only packages product: a network may divide data entry, clinical review, product preparation, final verification, and delivery among locations.
Centralization does not erase the legal character of each task. Identify which pharmacy received the order, which pharmacist performed DUR or another judgment function, which site selected and labeled product, which pharmacist authorized release, and which pharmacy delivers and counsels. A contract or shared computer system cannot turn pharmacist-only clinical judgment into a technician task or allow an unpermitted location to practice pharmacy. Each participating site remains subject to applicable permit, PIC, confidentiality, security, accuracy, record, and controlled-substance duties for the work it performs.
Do not automatically call centralized processing a prescription transfer . A transfer changes which pharmacy uses prescription information under the transfer rules; centralized processing assigns parts of a coordinated fulfillment workflow. If the facts do involve an actual transfer, apply the separate federal and Mississippi transfer restrictions. Records should make the chain auditable by identifying the pharmacies and personnel involved, the functions performed, the relevant times, and the final release decision.